Aliskiren Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double-Blind Placebo-Controlled Trial

BACKGROUND: The renin–angiotensin system is well recognized as a mediator of pathophysiological events in atherosclerosis. The benefits of renin inhibition in atherosclerosis, especially when used in combination with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihai, Georgeta, Varghese, Juliet, Kampfrath, Thomas, Gushchina, Liubov, Hafer, Lisa, Deiuliis, Jeffrey, Maiseyeu, Andrei, Simonetti, Orlando P., Lu, Bo, Rajagopalan, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698800/
https://www.ncbi.nlm.nih.gov/pubmed/23686372
http://dx.doi.org/10.1161/JAHA.112.004879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698800/
https://www.ncbi.nlm.nih.gov/pubmed/23686372
http://dx.doi.org/10.1161/JAHA.112.004879

Ejemplares similares